Clinical Study

A Study Of Exenatide For Weight Gain Associated With Olanzapine.

Posted Date: Aug 3, 2016

  • Investigator: Melissa Delbello
  • Specialties:
  • Type of Study: Drug

This is a research study to evaluate whether a medication commonly used to treat diabetes can reduce weight gain associated with Zyprexa. The study drug is not approved by the U.S. FDA for weight loss and is considered investigational. Study participants will receive either the study drug or a placebo (inactive study drug).

Criteria:

Adults 18 To 55 Years Old Who Have Gained Weight While Taking Zyprexa May Be Eligible To Participate.

Keywords:

Olanzapine, Overweight, Symbyax, Weight Gain, Zyprexa

For More Information:

Emily Rummelhoff
(513) 558-4295
emily.rummelhoff@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.